Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Zanidatamab in Combination With Pembrolizumab and Chemotherapy in HER2 and PD-L1 Positive Metastatic Gastroesophageal Adenocarcinoma (GEA) Patients [Phase 2]
Phase 2 clinical trial evaluating zanidatamab in combination with pembrolizumab and chemotherapy as first-line therapy for metastatic gastro…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Trans-Pacific Multicenter Collaborative Study of Minimally Invasive Proximal Versus Total Gastrectomy for Proximal Gastric and Gastroesophageal Junction Cancers
This multicenter clinical trial compares minimally invasive proximal gastrectomy with total gastrectomy for proximal gastric and gastroesoph…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study
This update describes the Moonshot Study's genetic analysis of blood and tissue samples from patients with advanced cancer; the study status…
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: Multigene Germline Panel Testing in Gastric Cancer Patients in Portugal
The clinical trial evaluating multigene germline panel testing in gastric cancer patients in Portugal has completed.
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Study of Sequential Systemic Therapy + Intraperitoneal Paclitaxel in Gastric/GEJ Peritoneal Carcinomatosis [Phase 2]
This Phase 2 clinical trial assesses sequential systemic therapy followed by intraperitoneal paclitaxel for gastric cancer with peritoneal c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-02-02Clinical Trial Update: A Study of PRT7732, an Oral SMARCA2 Degrader, in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation [Phase 1]
A Phase 1 study of PRT7732, an oral SMARCA2 degrader, in patients with SMARCA4-mutant advanced or metastatic solid tumors has been terminate…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: A Study to Evaluate Safety, Pharmacokinetics, & Activity of RO7496353 in Combination With a Checkpoint Inhibitor With or Without Standard-of-care Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors; Urothelial Carcinoma Substudy in Association With RO7496353 Study GO44010 [Phase 1]
Phase 1 study GO44010 evaluates RO7496353 in combination with a checkpoint inhibitor (with or without standard chemotherapy) in locally adva…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Identification of Biomarkers of Risk for Pre-neoplastic and Neoplastic Lesions for the Development of Gastric Cancer
A clinical trial is investigating biomarkers of risk for pre-neoplastic and neoplastic gastric lesions to inform the development of gastric …
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: A Study Collecting Health Information to Understand and Prevent Gastric Cancer
This recruiting clinical trial, sponsored by Memorial Sloan Kettering Cancer Center, seeks to collect health information to understand and p…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: The Thoracic Peri-Operative Integrative Surgical Care Evaluation Trial - Stage III [Phase 3]
This ClinicalTrials.gov entry describes the Thoracic Peri-Operative Integrative Surgical Care Evaluation Trial (Stage III), a Phase 3 study …
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy [Phase 1, Phase 2]
A Phase 1/2 trial of CHM-2101, an autologous CDH17 CAR-T therapy, is evaluating safety and early efficacy in neuroendocrine tumors, colorect…
-
CLINICAL_TRIALS withdrawal · 2026-01-29Clinical Trial Update: Biobanking Upper Gastrointestinal Tumors to Evaluate Response (BURGER With BACON)
The BURGER With BACON trial (NCT06283238) evaluating biobanking of upper gastrointestinal tumors to evaluate response has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: Camrelizumab Combined With or Without Apatinib and SOX of Neoadjuvant Treatment for Gastric Cancer [Phase 2]
Phase 2 neoadjuvant trial evaluating camrelizumab with or without apatinib plus SOX chemotherapy for gastric or gastroesophageal junction ad…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial update reports a Phase Ib/II study of TCC1727 in combination therapy for advanced solid tumors, including non-small cell…
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors [Phase 2]
Phase 2 trial update for HER3-DXd in locally advanced or metastatic solid tumors; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Perioperative Ivonescimab Plus S-1 and Oxaliplatin (SOX) for Locally Advanced Gastric or GEJ Adenocarcinoma [Phase 2]
This ClinicalTrials.gov entry describes a Phase 2 perioperative trial of Ivonescimab plus S-1 and oxaliplatin (SOX) for locally advanced gas…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Phase 1/2 Study to Evaluate TH9619 in the Treatment of Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial update indicates that TH9619 is being studied in a Phase 1/2 trial for advanced solid tumors, with recruitment ongoing a…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: A Prospective, Single-arm, Exploratory Study of Trifluridine/Tipiracil (TAS-102) Combined With Apatinib as Third-line Therapy for Advanced Gastric Cancer [NA]
A prospective, single-arm exploratory trial evaluating TAS-102 (trifluridine/tipiracil) in combination with apatinib as third-line therapy f…
-
CLINICAL_TRIALS trial_result · 2026-01-27Clinical Trial Update: Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SNB-101(SN-38) in Patients With Tumors [Phase 1]
Phase 1 dose-finding study evaluating safety, tolerability, and pharmacokinetics of SNB-101 (SN-38) in patients with colorectal, breast, pan…
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: XELOX for 4 Months Versus 6 Months in Gastric Cancer (LOMAC) [Phase 3]
This Phase 3 clinical trial compares 4 months vs 6 months of XELOX chemotherapy for gastric cancer; the study is currently active but not re…
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating BOLD-100 in combination with FOLFOX for advanced solid tumors, including colorectal cancer, pancreatic…
-
CLINICAL_TRIALS other · 2026-01-27Clinical Trial Update: Adebrelimab Combined With Induction Chemotherapy or SHR-8068 for Mismatch Repair-Deficient/Microsatellite Instability-High (dMMR/MSI-H) Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma：A Randomized, Non-comparative Phase 2 Study [Phase 2]
A Phase 2 trial update describing a randomized study of Adebrelimab with induction chemotherapy or SHR-8068 in locally advanced dMMR/MSI-H g…
-
EMA approval · 2026-01-26EMA Authorised: Tevimbra (tislelizumab) — Beone Medicines Ireland Limited
EMA authorised Tevimbra (tislelizumab) from Beone Medicines Ireland Limited for multiple cancer indications, including esophageal squamous c…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Adjuvant Oxaliplatin Plus S-1 Versus Docetaxel Plus S-1 for Stage III Gastric Cancer [Phase 3]
A Phase 3 randomized trial compares adjuvant oxaliplatin plus S-1 versus docetaxel plus S-1 for stage III gastric cancer; recruitment is ong…
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: Perioperative Oxaliplatin With S-1 Combined H. Pylori Eradication in the Management of Locally Advanced Gastric Cancer [Phase 2]
A Phase 2 clinical trial is evaluating perioperative oxaliplatin with S-1 in combination with Helicobacter pylori eradication for locally ad…